The Safe Baby Formula Act of 2026 directs the Department of Health and Human Services to study the health effects of arsenic, cadmium, mercury, and lead in infant formula within one year of passing. Following this study, the agency must set specific safety limits for these toxic metals in formula products within 90 days. When establishing these limits, the law requires the department to consider how easy it is to meet the standards, its ability to enforce rules on imported goods, and the potential impact on food security. This legislation directly affects infant formula manufacturers and regulators by mandating the creation of evidence-based safety standards for heavy metals.
The Consumer Appeal Rights Enforcement Act strengthens rules for employee benefit plans by allowing the Department of Labor to impose fines on entities that fail to follow claims procedures or external review requirements. It defines violations as either global failures to have compliant processes or individual instances where plans do not provide proper notices, timely decisions, or requested information to participants. Penalties range from $1,000 per participant for global violations to $1,000 per day for individual violations, with options to triple these amounts if issues are not corrected within specific timeframes. The bill also repeals a previous provision that allowed private lawsuits for certain procedural violations, shifting enforcement authority to the Secretary of Labor.
The Medicaid Dental Benefit Act of 2026 mandates that Medicaid programs cover a range of dental and oral health services for adults starting in 2027, including dentures, implants, and treatments for pain and emergencies. To help states afford this expansion, the bill provides 100 percent federal funding for these specific services for a 12-quarter period beginning in 2027, while allowing states the option to add extra dental benefits if they choose. In addition to expanding coverage, the legislation requires the federal government to develop standardized quality measures to track adult oral health outcomes and report on disparities based on race, ethnicity, and other demographics. The bill also directs the creation of an outreach program to help eligible adults find care and establishes a timeline for a comprehensive report on access barriers and reimbursement issues.
The Shandra Eisenga TB Study Act of 2026 directs the Department of Health and Human Services to conduct a study on creating a standardized test for detecting tuberculosis in human cadaver tissue. This initiative aims to improve donor screening and transplant safety by evaluating current scientific knowledge, testing methodologies, and potential implementation barriers. The study will involve collaboration with various health agencies and stakeholders, with a focus on diverse populations and multiple collection sites. By the end of 2029, the department must submit a report to Congress detailing its findings and recommending necessary steps to develop or implement this new testing strategy.
The Green New Deal for Health Act establishes a comprehensive federal framework to address the intersection of climate change and public health by creating new offices, expanding funding, and mandating specific actions across the health care sector. It directly affects hospitals, health care providers, medical manufacturers, health professions schools, and communities identified as environmentally or medically underserved. Key provisions include establishing an Office of Climate Change and Health Equity to develop a national strategic action plan, requiring hospitals to provide detailed notifications and mitigation plans before discontinuing services or closing, and offering grants to modernize medical facilities for climate resilience. The bill also mandates that the health care sector disclose climate risks associated with medical supplies, expands Medicare coverage for home resiliency services like heat pumps for vulnerable patients, and allocates billions in funding to train health workers on climate-related health risks. Additionally, the legislation creates a research initiative to study climate impacts on health and establishes requirements for green, zero-emission medical manufacturing and supply chains.
The Childhood Disability Benefits Fairness Act changes how Medicaid eligibility is determined for children who receive Social Security child's insurance benefits. Under current rules, these children might be denied Medicaid because their Social Security payments count as income, even though the payments are meant to replace lost wages due to a parent's disability. This bill ensures that children in this situation are treated as if they are receiving Supplemental Security Income benefits instead, which allows them to qualify for Medicaid regardless of their Social Security income. The change applies to all new eligibility decisions made after the law is passed, aiming to provide consistent access to healthcare coverage for disabled children with low family incomes.
The CHARTS Act authorizes $5 million over two years to provide grants to long-term care and post-acute care providers, such as nursing facilities and home health agencies, for implementing specific health information technology systems. These funds, capped at $500,000 per provider, must be used to develop tools that enable real-time data sharing among doctors, insurers, and government programs while improving care coordination and reducing duplicate services. The Department of Health and Human Services will prioritize grants for facilities serving Medicare and Medicaid beneficiaries and will ensure recipients represent a diverse range of geographic and demographic populations. Additionally, the bill requires the agency to submit reports evaluating how these technologies impact patient outcomes, costs, and care transitions over a six-year period.
Baby Brent's Bill directs the Federal Trade Commission to investigate and regulate the advertising and marketing of formula designed for premature infants. The legislation requires the agency to create rules that prevent companies from hiding potential health risks or downplaying the differences between breast milk-based supplements and cow-based ones. These regulations would apply to manufacturers and importers of specialized infant formula intended for babies born before 37 weeks or with low birth weight. The bill aims to ensure parents receive clear information about product safety and options while maintaining the ability to seek legal recourse if their infants are harmed.
The State of Men's Health Act aims to address rising health risks and premature death among men by establishing a new Office of Men's Health within the Department of Health and Human Services. Before creating this office, the bill requires the Government Accountability Office to conduct a study on men's health disparities and recommend ways to improve federal coordination and awareness. Once established, the new office will coordinate screening programs for conditions like prostate cancer and diabetes, maintain a database of best practices, and report its findings to Congress. The legislation does not authorize new funding, meaning the office must operate using existing budget resources.
The PREVENT ESRD Act establishes a ten-year demonstration program to help prevent kidney disease from progressing to end-stage renal disease, which places a heavy financial burden on Medicare. Starting in 2027, the program invites private health plans, Medicaid programs, and other insurers to voluntarily join an initiative where they must cover specific kidney care services, such as screenings, medications, and nutrition support, with little to no cost to patients. Participating plans can earn shared savings payments from Medicare if they successfully reduce the rate of kidney disease progression compared to a benchmark based on their historical data, provided they maintain high quality of care and do not avoid enrolling high-risk patients. The legislation also requires the Department of Health and Human Services to hold listening sessions and gather public input to refine the program's scope and ensure it meets the needs of patients and providers.
